ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

More Clinical Trials Money Top Priority, DeVita Says; Drug Discovery Groups RFA Gets 12 Applications

February 24, 1984

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004

NCI Director Harold Varmus Plans New Center For Cancer Genomics To Lead The Cancer Genome Atlas Program.

September 10, 2010

Nine More Reported In Range Of CCOP 3 Recompetition

February 2, 1990

Pancreatic Lesions Related To Corn Oil Status Reports Made

March 25, 1983

Rush-Presbyterian Professor Committed Misconduct, ORI Says

October 6, 1995